Ascendis Pharma A/SASNDNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank21
3Y CAGR-49.7%
5Y CAGR-56.3%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-49.7%/yr
vs -12.4%/yr prior
5Y CAGR
-56.3%/yr
Recent acceleration
Acceleration
-37.3pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0x
Contraction
Streak
5 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 15.90 | -24.9% |
| 2024 | 21.17 | -12.0% |
| 2023 | 24.05 | -80.8% |
| 2022 | 124.97 | -85.0% |
| 2021 | 833.09 | -16.1% |
| 2020 | 993.40 | +130.3% |
| 2019 | 431.35 | +103.3% |
| 2018 | 212.13 | -70.9% |
| 2017 | 728.64 | +557.3% |
| 2016 | 110.85 | - |